2Turner A,Tssamitros M,Bellomo R.Myocardial cell injury in septic shock[J].Crit Care Med,1999,27(9):1775.
3Parrillo JE,Parker MM,Natanson C,et al.Septic shock in humans:advances in the understanding of prognosis,cardiovascular dysfunction,and therapy[J].Ann Intern Med,1990,113(3):227-242.
4Karima R,Matsumoto S,Higashi H,et al.The molecular pathogenesis of endotoxic shock and organ failure[J].Mol Med Today,1999,5(3):123-132.
5Peake SL,Moran JL,Leppard PI.N-acetyl-L-cysteine depresses cardiac performance in patients with septic shock[J].Crit Care Med,1996,24(12):1302-1310.
6Wang LF,Zhang HY.A theoretical investigantion on DPPH radical-scavenging mechanism of edaravone[J].Bioorg Med Chem Lett,2003,13(21):3789-3792.
7Hayashi T,Mori T,Sohmiya K,et al.Efficacy of edaravone,a free radical scavenger,on left ventricular function and structure in diabetes mellitus[J].J Cardiovase Pharmacol,2003,41(6):923-929.
8Wu TW,Zeng LH,Wu J,et al.Myocardial protection of MCI-186 in rabbit ischemia-reperfusion[J].Life Sci,2002,27(19):2249-2255.
9Closa D,Folch-Puy E.Oxygen free radicals and the systemic inflammatory respinse[J].IUBMB Life,2004,56(4):185-191.
